Skip to main content
BFNH logo

BFNH · Bioforce Nanosciences Holdings, Inc. · Shareholders & Ownership

Track BFNH — free
$6.70 -0.05 (-0.74%) At close · Oct 20
Market Cap
$225.11M
Shares
33.55M
Volume · Oct 20 3720 Avg daily vol (3M) 9767

Every disclosed holder of BFNH in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns BFNH

Holder group Shares % Out
Institutional (13F) 0 0.00%
Insiders (Forms 3, 4, 5) 0 0.00%
13D/G-only blocks 26,700,000 79.59%
Remaining 6,849,005 20.41%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 33,549,005, the issuer's latest cover-page count restated onto today's split basis.

Insiders are listed but not summed: the issuer has more than one class of common stock and Forms 3, 4 and 5 report one issuer-wide balance across them.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of BFNH

# Holder Shares
1
Nexus Capital Investments, Inc.
13D CIK 2132998 · Unknown · Apr 22, 2026
Item 4 purpose: none of the classified purposes
26,700,000
1.1
Nexus Capital Investments, Inc.
Insider CIK 2132998 · Apr 22, 2026
10% Owner, issuer-wide, not summed
26,700,000
2
KAISER RICHARD KAISER
Insider CIK 1663787 · Aug 31, 2026
Director, CFO, 10% Owner, issuer-wide, not summed
1,234,447
3
Mager Scott
Insider CIK 2139696 · Aug 31, 2026
Director, issuer-wide, not summed
1,000,000

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1310488 CUSIP 09064C206 Visit website Investor relations